Figure 2

Quantification of urine-derived exosomes, in healthy donors, and Prostate Cancer patients. The quantity of exosomes present in each preparation was measured using the BCA protein assay. Values were corrected for urine-specimen volume, and are represented as ng Exosomes per ml of urine. Preparations from 10 healthy donors and 10 PCa patients undergoing standard therapy, at ADT₄ (after 4 weeks ADT), ADT₁₂ (after 3 months of ADT), and at RT₂₀ (and after 20-fractions of radiotherapy) are compared. Bars represent mean+SE. *p < 0.5 using the Wilcoxon matched pairs test are shown.